Hoth Therapeutics to Present at the Benzinga Biotech Small Cap Conference on March 24, 2021
NEW YORK, March 22, 2021 /PRNewswire/ --Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Robb Knie, Chief Executive Officer, is scheduled to present at the Benzinga Biotech Small Cap Conference on Wednesday, March 24th at 12:10 p.m. ET. Following the presentation, Mr. Knie will also participate in a panel discussion on the same day at 12:50 p.m. ET, entitled 'Coming Together to Address Unmet Medical Needs'.
To attend the conference and listen to the presentation and panel discussion via webcast, please register by visiting https://www.benzinga.com/events/small-cap/biotech/.
For more information regarding the conference or to schedule a one-on-one meeting with management, please email firstname.lastname@example.org or your Benzinga representative directly.
About Hoth Therapeutics, Inc.
View original content to download multimedia:http://www.prnewswire.com/news-releases/hoth-therapeutics-to-present-at-the-benzinga-biotech-small-cap-conference-on-march-24-2021-301252395.html
SOURCE Hoth Therapeutics, Inc.
Company Codes: NASDAQ-NMS:HOTH